PMID: 7025156Mar 1, 1981Paper

Serum antibody responses of high-risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae

Reviews of Infectious Diseases
G S GiebinkG Schiffman

Abstract

Pneumococcal antibody was measured in the sera of splenectomized children, children with neprotic syndrome, adult with chronic renal failure, adults maintained on hemodialysis, adult recipients of renal allografts, and normal children and adults before and after vaccination with a polyvalent vaccine against Streptococcus pneumoniae. The medical conditions of these patients are associated with increased morbidity and mortality due to pneumococcal disease. Nonimmunosuppressed splenectomized children, children with steroid-responsive nephrotic syndrome, and adults maintained on hemodialysis had normal concentrations of antibody in serum and normal antibody responses to pneumococcal vaccine. Children with steroid-resistant nephrotic syndrome and adult recipients of renal allografts had low concentrations of antibody in serum before and after vaccination but showed an antibody increase after vaccination. During the first year after vaccination of the splenectomized patients, serum antibody concentrations declined linearly by 24%-32% from the peak antibody level. These results suggest that immunization with pneumococcal polysaccharides may reduce the indicence of pneumococcal disease in some high-risk patients but not in others.

Citations

Nov 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G A Bruyn, R van Furth
Apr 1, 1991·Acta paediatrica Scandinavica·H B Konradsen, J Henrichsen
Jun 28, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B MikolucR Motkowski
Sep 1, 2015·British Journal of Haematology·Ernest KucharMonika Karlikowska
May 27, 2008·Pulmonary Pharmacology & Therapeutics·Fulvio BraidoGiorgio Walter Canonica
Dec 4, 2004·Vaccine·Christian TheilackerJohannes Huebner
Jan 1, 1992·Journal of the American Geriatrics Society·D C Powers
Jul 18, 2009·International Journal of Surgery·D P HarjiP N Nesargikar
Aug 1, 1993·British Journal of Haematology·J E Lortan
Jul 13, 2001·Infectious Disease Clinics of North America·V SumarajuS M Smith
Jan 1, 1990·Scandinavian Journal of Infectious Diseases·H B KonradsenJ Henrichsen
Aug 16, 2017·Rheumatology and Therapy·James BluettDeborah P M Symmons
Sep 3, 2010·Transplantation·Monika LindemannOliver Witzke
Jan 31, 2019·Human Vaccines & Immunotherapeutics·Koji Kuronuma, Hiroki Takahashi
Jan 8, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Christopher M BeardenMark D Pescovitz
Oct 1, 1982·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·F K PedersenJ Ellegaard
Feb 1, 1984·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology·I S AabergeE C Groeng
Feb 11, 1998·Clinical Microbiology Reviews·L A Pirofski, A Casadevall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.